Walleye Trading’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,200
Closed -$389K 4720
2025
Q4
$389K Sell
3,200
-2,400
-43% -$301K ﹤0.01% 2989
2025
Q3
$628K Sell
5,600
-4,200
-43% -$492K ﹤0.01% 2581
2025
Q2
$1.31M Buy
9,800
+5,000
+104% +$549K ﹤0.01% 2006
2025
Q1
$323K Sell
4,800
-18,900
-80% -$1.3M ﹤0.01% 2793
2024
Q4
$1.48M Buy
23,700
+22,900
+2,863% +$2.13M ﹤0.01% 1883
2024
Q3
$126K Sell
800
-600
-43% -$92.5K ﹤0.01% 3240
2024
Q2
$211K Sell
1,400
-3,000
-68% -$360K ﹤0.01% 3061
2024
Q1
$325K Buy
+4,400
New +$363K ﹤0.01% 3129
2023
Q4
Sell
-600
Closed -$32.9K 5499
2023
Q3
$32.9K Sell
600
-3,300
-85% -$238K ﹤0.01% 4300
2023
Q2
$328K Sell
3,900
-2,100
-35% -$161K ﹤0.01% 3102
2023
Q1
$454K Buy
+6,000
New +$415K ﹤0.01% 2884
2022
Q4
Sell
-100
Closed -$4K 5415
2022
Q3
$4K Buy
+100
New +$4.35K ﹤0.01% 4685

Other funds holding TMDX

Walleye Trading's TMDX Position: Q1 2026 in Review

Walleye Trading sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 1,200 shares — an estimated $146K sold.

Walleye Trading first reported a position in TMDX in Q2 2021 and held it in 11 quarters. The position peaked at $336K in Q3 2023. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Walleye Trading reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 1,200 Transmedics shares in Q1 2026, an estimated $146K.
  • Walleye Trading first reported a position in Transmedics in Q2 2021 and held it in 11 quarters.
  • Walleye Trading's Transmedics position peaked at $336K in Q3 2023.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.